GSK180
Product Specifications
UNSPSC Description
GSK180 is a selective, competitive, and potent inhibitor of kynurenine-3-monooxygenase (KMO), a key enzyme of tryptophan metabolism (IC50, ~6 nM), but shows negligible activity against other enzymes on the tryptophan pathway. GSK180 rapidly changes levels of kynurenine pathway metabolites, and acts as a useful tool to probe the therapeutic potential of KMO inhibition[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk180.html
Purity
99.04
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CCN1C(OC2=CC(Cl)=C(Cl)C=C12)=O
Molecular Weight
276.07
References & Citations
[1]Mole DJ, et al. Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis. Nat Med. 2016 Feb;22(2):202-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-112179/GSK180-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-112179/GSK180-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1799725-26-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS951883-01 0.5 mg (E-Coli)
Recombinant Mouse Ephrin type-B receptor 4 (Ephb4), partial
Ask
View Details MBS951883-02 0.05 mg (Baculovirus)
Recombinant Mouse Ephrin type-B receptor 4 (Ephb4), partial
Ask
View Details MBS951883-03 0.5 mg (Yeast)
Recombinant Mouse Ephrin type-B receptor 4 (Ephb4), partial
Ask
View Details MBS951883-04 0.05 mg (Mammalian-Cell)
Recombinant Mouse Ephrin type-B receptor 4 (Ephb4), partial
Ask
View Details